Data:
{
"symbol": "ROIV",
"price": 34.435,
"marketCap": 24873193022,
"beta": 1.103,
"lastDividend": 0,
"range": "17.28-42.5",
"change": 0.905,
"changePercentage": 2.69908,
"volume": 1596552.10997,
"averageVolume": 6771264,
"companyName": "Roivant Sciences Ltd.",
"currency": "USD",
"cik": "0001635088",
"isin": "BMG762791017",
"cusip": "G76279101",
"exchangeFullName": "NASDAQ Global Market",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://roivant.com",
"description": "Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.",
"ceo": "Matthew Gline",
"sector": "Healthcare",
"country": "GB",
"fullTimeEmployees": "721",
"phone": "44 2074 003 347",
"address": "50 Broadway",
"city": "London",
"state": "GL",
"zip": "SW1H 0DB",
"image": "https://images.financialmodelingprep.com/symbol/ROIV.png",
"ipoDate": "2020-12-08",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "ROIV",
"name": "Roivant Sciences Ltd.",
"price": 34.5343,
"changePercentage": 2.99523,
"change": 1.0043,
"volume": 1899571.02393,
"dayLow": 33.6,
"dayHigh": 34.585,
"yearHigh": 42.5,
"yearLow": 17.28,
"marketCap": 24944919697,
"priceAvg50": 36.6334,
"priceAvg200": 30.78783,
"exchange": "NASDAQ",
"open": 33.78,
"previousClose": 33.53,
"timestamp": 1792427190,
"quote_spread": {},
"chart_vwap_daily": [
{
"t": "2026-09-08",
"v": 41.3252,
"c": 41.48
},
{
"t": "2026-09-09",
"v": 41.7384,
"c": 41.81
},
{
"t": "2026-09-10",
"v": 40.7767,
"c": 40.94
},
{
"t": "2026-09-11",
"v": 41.0271,
"c": 40.82
},
{
"t": "2026-09-14",
"v": 40.9998,
"c": 41.02
},
{
"t": "2026-09-15",
"v": 39.6641,
"c": 39.5
},
{
"t": "2026-09-16",
"v": 39.7858,
"c": 39.57
},
{
"t": "2026-09-17",
"v": 40.0244,
"c": 39.98
},
{
"t": "2026-09-18",
"v": 39.8548,
"c": 39.77
},
{
"t": "2026-09-21",
"v": 39.1227,
"c": 38.99
},
{
"t": "2026-09-22",
"v": 38.407,
"c": 38.22
},
{
"t": "2026-09-23",
"v": 37.1144,
"c": 36.82
},
{
"t": "2026-09-24",
"v": 36.2487,
"c": 36.13
},
{
"t": "2026-09-25",
"v": 35.8317,
"c": 35.8
},
{
"t": "2026-09-28",
"v": 36.7883,
"c": 36.98
},
{
"t": "2026-09-29",
"v": 36.2884,
"c": 36.5
},
{
"t": "2026-09-30",
"v": 36.602,
"c": 36.57
},
{
"t": "2026-10-01",
"v": 35.8975,
"c": 35.5
},
{
"t": "2026-10-02",
"v": 35.668,
"c": 35.72
},
{
"t": "2026-10-05",
"v": 35.8711,
"c": 35.78
},
{
"t": "2026-10-06",
"v": 35.4051,
"c": 35.53
},
{
"t": "2026-10-07",
"v": 35.0245,
"c": 34.75
},
{
"t": "2026-10-08",
"v": 34.0534,
"c": 34.21
},
{
"t": "2026-10-09",
"v": 35.2057,
"c": 35.44
},
{
"t": "2026-10-12",
"v": 34.7964,
"c": 34.59
},
{
"t": "2026-10-13",
"v": 33.5989,
"c": 33.35
},
{
"t": "2026-10-14",
"v": 33.6356,
"c": 33.62
},
{
"t": "2026-10-15",
"v": 34.0615,
"c": 34.04
},
{
"t": "2026-10-16",
"v": 33.509,
"c": 33.53
},
{
"t": "2026-10-19",
"v": 34.133,
"c": 34.525
}
],
"vwap_summary": {
"days": 30,
"days_above": 12,
"days_below": 18,
"pct_days_above": 40,
"position": "above",
"gap_pct": 1.15,
"streak_days": 2
}
}
Data:
{
"volume": 1899571.02393,
"avgVolume": 6771264,
"short_ratio": [
{
"symbol": "ROIV",
"file_date": "2026-10-16",
"date": "20261016",
"short_volume": 1188338,
"short_exempt_volume": 106,
"total_volume": 1768753,
"short_volume_ratio": 0.6719,
"signal": "Bearish"
}
],
"volume_profile": {
"poc": 35.8,
"vah": 37.2,
"val": 34.2,
"profile": [
{
"price": 33.29,
"volume": 165547
},
{
"price": 33.38,
"volume": 2215214
},
{
"price": 33.48,
"volume": 2304998
},
{
"price": 33.58,
"volume": 2543985
},
{
"price": 33.67,
"volume": 2279162
},
{
"price": 33.77,
"volume": 631959
},
{
"price": 33.87,
"volume": 570650
},
{
"price": 33.96,
"volume": 1361087
},
{
"price": 34.06,
"volume": 2038513
},
{
"price": 34.16,
"volume": 1104858
},
{
"price": 34.25,
"volume": 1579689
},
{
"price": 34.35,
"volume": 1389953
},
{
"price": 34.45,
"volume": 1268453
},
{
"price": 34.54,
"volume": 694005
},
{
"price": 34.64,
"volume": 1751231
},
{
"price": 34.74,
"volume": 1050577
},
{
"price": 34.83,
"volume": 1468813
},
{
"price": 34.93,
"volume": 507357
},
{
"price": 35.03,
"volume": 1966802
},
{
"price": 35.12,
"volume": 2156839
},
{
"price": 35.22,
"volume": 2119844
},
{
"price": 35.32,
"volume": 2471355
},
{
"price": 35.41,
"volume": 2553164
},
{
"price": 35.51,
"volume": 2270572
},
{
"price": 35.61,
"volume": 1146287
},
{
"price": 35.7,
"volume": 2220070
},
{
"price": 35.8,
"volume": 4999966
},
{
"price": 35.9,
"volume": 2734321
},
{
"price": 35.99,
"volume": 1950925
},
{
"price": 36.09,
"volume": 3355262
},
{
"price": 36.19,
"volume": 2930660
},
{
"price": 36.28,
"volume": 2759761
},
{
"price": 36.38,
"volume": 1866945
},
{
"price": 36.48,
"volume": 2362838
},
{
"price": 36.57,
"volume": 1121796
},
{
"price": 36.67,
"volume": 2319748
},
{
"price": 36.77,
"volume": 711903
},
{
"price": 36.86,
"volume": 1529492
},
{
"price": 36.96,
"volume": 1401772
},
{
"price": 37.06,
"volume": 1671790
},
{
"price": 37.15,
"volume": 546966
},
{
"price": 37.25,
"volume": 440268
},
{
"price": 37.35,
"volume": 900424
},
{
"price": 37.44,
"volume": 601977
},
{
"price": 37.54,
"volume": 603318
},
{
"price": 37.64,
"volume": 106088
},
{
"price": 37.73,
"volume": 45891
},
{
"price": 37.83,
"volume": 42418
},
{
"price": 37.93,
"volume": 222268
},
{
"price": 38.02,
"volume": 204124
},
{
"price": 38.12,
"volume": 135897
},
{
"price": 38.22,
"volume": 1394993
},
{
"price": 38.31,
"volume": 744956
},
{
"price": 38.41,
"volume": 617353
},
{
"price": 38.51,
"volume": 629877
},
{
"price": 38.6,
"volume": 329958
},
{
"price": 38.7,
"volume": 356998
},
{
"price": 38.8,
"volume": 203794
},
{
"price": 38.89,
"volume": 380845
},
{
"price": 38.99,
"volume": 229711
}
],
"sessions": 20
}
}
Data:
{
"symbol": "ROIV",
"marketCap": 24873193022,
"enterpriseValueTTM": 23728277406,
"evToSalesTTM": 3150.808420339883,
"evToOperatingCashFlowTTM": -29.321760032914856,
"evToFreeCashFlowTTM": -29.156302471638448,
"evToEBITDATTM": -82.68086618820332,
"netDebtToEBITDATTM": 3.9762533533080164,
"currentRatioTTM": 16.720838637108915,
"incomeQualityTTM": 2.2352975292889457,
"grahamNumberTTM": null,
"grahamNetNetTTM": 5.622237831401493,
"taxBurdenTTM": 0.9184731613081275,
"interestBurdenTTM": 1,
"workingCapitalTTM": 4458477000,
"investedCapitalTTM": 4548683000,
"returnOnAssetsTTM": -0.05017381536167107,
"operatingReturnOnAssetsTTM": -0.24765404768192378,
"returnOnTangibleAssetsTTM": -0.05017381536167107,
"returnOnEquityTTM": -0.06124059665919293,
"returnOnInvestedCapitalTTM": -0.2713604066034937,
"returnOnCapitalEmployedTTM": -0.2720294491816464,
"earningsYieldTTM": -0.010727138132886501,
"freeCashFlowYieldTTM": -0.032724146002488255,
"capexToOperatingCashFlowTTM": -0.005674847194268071,
"capexToDepreciationTTM": 1.611578947368421,
"capexToRevenueTTM": 0.609798194370685,
"salesGeneralAndAdministrativeToRevenueTTM": 85.23287307488052,
"researchAndDevelopementToRevenueTTM": 97.04049389272437,
"stockBasedCompensationToRevenueTTM": 35.250663834306955,
"intangiblesToTotalAssetsTTM": 0,
"averageReceivablesTTM": 791531000,
"averagePayablesTTM": 21543000,
"averageInventoryTTM": 0,
"daysOfSalesOutstandingTTM": 38439.704593733404,
"daysOfPayablesOutstandingTTM": 6470.43109540636,
"daysOfInventoryOutstandingTTM": 0,
"operatingCycleTTM": 38439.704593733404,
"cashConversionCycleTTM": 31969.273498327042,
"freeCashFlowToEquityTTM": -813954000,
"freeCashFlowToFirmTTM": -813954000,
"tangibleAssetValueTTM": 4921869000,
"netCurrentAssetValueTTM": 4357456000,
"grossProfitMarginTTM": 0.8121348911311737,
"ebitMarginTTM": -38.486457780138075,
"ebitdaMarginTTM": -38.1080722251726,
"operatingProfitMarginTTM": -181.40918746680828,
"pretaxProfitMarginTTM": -38.486457780138075,
"continuousOperationsProfitMarginTTM": -55.04460966542751,
"netProfitMarginTTM": -35.3487785448752,
"bottomLineProfitMarginTTM": -35.3487785448752,
"receivablesTurnoverTTM": 0.009495390348538312,
"payablesTurnoverTTM": 0.05641046085153883,
"inventoryTurnoverTTM": 0,
"fixedAssetTurnoverTTM": 0.08349777176684478,
"assetTurnoverTTM": 0.0014193931849151597,
"quickRatioTTM": 16.720838637108915,
"solvencyRatioTTM": -0.6848168601023337,
"cashRatioTTM": 4.402125506429763,
"priceToEarningsRatioTTM": -90.60526315789474,
"priceToEarningsGrowthRatioTTM": 0.7550438596491232,
"forwardPriceToEarningsGrowthRatioTTM": -3.9621163572100064,
"priceToEarningsDilutedRatioTTM": -78.24999999999999,
"priceToEarningsDilutedGrowthRatioTTM": 0.6572405212197994,
"priceToBookRatioTTM": 5.864982742491445,
"priceToSalesRatioTTM": 3301.856267392459,
"priceToFreeCashFlowRatioTTM": -30.554037950547574,
"priceToOperatingCashFlowRatioTTM": -30.66164928106247,
"debtToAssetsRatioTTM": 0.02019262062533579,
"debtToEquityRatioTTM": 0.025323820987206452,
"debtToCapitalRatioTTM": 0.024698364037640388,
"longTermDebtToCapitalRatioTTM": 0,
"financialLeverageRatioTTM": 1.2541126512044958,
"workingCapitalTurnoverRatioTTM": 0.0016120510878080932,
"operatingCashFlowRatioTTM": -2.8538520396469713,
"operatingCashFlowSalesRatioTTM": -107.45631970260223,
"freeCashFlowOperatingCashFlowRatioTTM": 1.005674847194268,
"debtServiceCoverageRatioTTM": 0,
"interestCoverageRatioTTM": 0,
"shortTermOperatingCashFlowCoverageRatioTTM": 0,
"operatingCashFlowCoverageRatioTTM": -7.553391443930118,
"capitalExpenditureCoverageRatioTTM": -176.2161985630307,
"dividendPaidAndCapexCoverageRatioTTM": -176.2161985630307,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 0.010449837782570283,
"netIncomePerShareTTM": -0.3693890016059467,
"interestDebtPerShareTTM": 0.1486618452041916,
"cashPerShareTTM": 5.330474461940149,
"bookValuePerShareTTM": 6.828562485005499,
"tangibleBookValuePerShareTTM": 6.828562485005499,
"shareholdersEquityPerShareTTM": 5.8704350058111405,
"operatingCashFlowPerShareTTM": -1.1229011096042043,
"capexPerShareTTM": 0.006372292211277922,
"freeCashFlowPerShareTTM": -1.1292734018154822,
"netIncomePerEBTTTM": 0.9184731613081275,
"ebtPerEbitTTM": 0.2121527488081594,
"priceToFairValueTTM": 5.864982742491445,
"debtToMarketCapTTM": 0,
"effectiveTaxRateTTM": -0.43023319994480475,
"enterpriseValueMultipleTTM": -82.66828347559489,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 29053000
},
{
"date": "2026",
"revenue": 8260000
}
],
"dcf": {
"symbol": "ROIV",
"date": "2026-10-19",
"dcf": 2.892403412855405,
"Stock Price": 33.53
},
"statements": {
"income": [
{
"date": "2026-03-31",
"symbol": "ROIV",
"reportedCurrency": "USD",
"cik": "0001635088",
"filingDate": "2026-05-20",
"acceptedDate": "2026-05-20 07:17:14",
"fiscalYear": "2025",
"period": "FY",
"revenue": 8260000,
"costOfRevenue": 1285000,
"grossProfit": 6975000,
"researchAndDevelopmentExpenses": 681812000,
"generalAndAdministrativeExpenses": 610466000,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 610466000,
"otherExpenses": 0,
"operatingExpenses": 1292278000,
"costAndExpenses": 1293563000,
"netInterestIncome": 178109000,
"interestIncome": 178109000,
"interestExpense": 0,
"depreciationAndAmortization": 3348000,
"ebitda": -261230000,
"ebit": -264578000,
"nonOperatingIncomeExcludingInterest": -1020725000,
"operatingIncome": -1285303000,
"totalOtherIncomeExpensesNet": 1020725000,
"incomeBeforeTax": -264578000,
"incomeTaxExpense": 133329000,
"netIncomeFromContinuingOperations": -397907000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -299771000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -299771000,
"eps": -0.43,
"epsDiluted": -0.43,
"weightedAverageShsOut": 693864530,
"weightedAverageShsOutDil": 693864530
}
],
"balance_sheet": [
{
"date": "2026-03-31",
"symbol": "ROIV",
"reportedCurrency": "USD",
"cik": "0001635088",
"filingDate": "2026-05-20",
"acceptedDate": "2026-05-20 07:17:14",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 1423090000,
"shortTermInvestments": 2872601000,
"cashAndShortTermInvestments": 4295691000,
"netReceivables": 789835000,
"accountsReceivables": 0,
"otherReceivables": 789835000,
"inventory": 0,
"prepaids": 0,
"otherCurrentAssets": 81858000,
"totalCurrentAssets": 5167384000,
"propertyPlantEquipmentNet": 92402000,
"goodwill": 0,
"intangibleAssets": 0,
"goodwillAndIntangibleAssets": 0,
"longTermInvestments": 415877000,
"taxAssets": 19358000,
"otherNonCurrentAssets": 33024000,
"totalNonCurrentAssets": 560661000,
"otherAssets": 0,
"totalAssets": 5728045000,
"totalPayables": 63691000,
"accountPayables": 18002000,
"otherPayables": 45689000,
"accruedExpenses": 87325000,
"shortTermDebt": 11147000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 45689000,
"deferredRevenue": 0,
"otherCurrentLiabilities": 119081000,
"totalCurrentLiabilities": 281244000,
"longTermDebt": 0,
"capitalLeaseObligationsNonCurrent": 96291000,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 19358000,
"otherNonCurrentLiabilities": 38739999,
"totalNonCurrentLiabilities": 154388999,
"otherLiabilities": 0,
"capitalLeaseObligations": 96291000,
"totalLiabilities": 435633000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 0,
"retainedEarnings": -501814000,
"additionalPaidInCapital": 5024826000,
"accumulatedOtherComprehensiveIncomeLoss": 4358000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 4527370000,
"totalEquity": 5292412000,
"minorityInterest": 765042000,
"totalLiabilitiesAndTotalEquity": 5728045000,
"totalInvestments": 3288478000,
"totalDebt": 107438000,
"netDebt": -1315652000
}
],
"cash_flow": [
{
"date": "2026-03-31",
"symbol": "ROIV",
"reportedCurrency": "USD",
"cik": "0001635088",
"filingDate": "2026-05-20",
"acceptedDate": "2026-05-20 07:17:14",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -397907000,
"depreciationAndAmortization": 3348000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 346165000,
"changeInWorkingCapital": -621796000,
"accountsReceivables": -770235000,
"inventory": 0,
"accountsPayables": 3418000,
"otherWorkingCapital": 145021000,
"otherNonCashItems": -80159000,
"netCashProvidedByOperatingActivities": -750349000,
"investmentsInPropertyPlantAndEquipment": -8209000,
"acquisitionsNet": 0,
"purchasesOfInvestments": 0,
"salesMaturitiesOfInvestments": -37488000,
"otherInvestingActivities": -636636000,
"netCashProvidedByInvestingActivities": -682333000,
"netDebtIssuance": 0,
"longTermNetDebtIssuance": 0,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 143607000,
"netCommonStockIssuance": 143607000,
"commonStockIssuance": 463110000,
"commonStockRepurchased": -319503000,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -9371000,
"netCashProvidedByFinancingActivities": 134236000,
"effectOfForexChangesOnCash": 3767000,
"netChangeInCash": -1294679000,
"cashAtEndOfPeriod": 1430982000,
"cashAtBeginningOfPeriod": 2725661000,
"operatingCashFlow": -750349000,
"capitalExpenditure": -8209000,
"freeCashFlow": -758558000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 34.5081,
"rsi": 43.87841895630158,
"sma20": 35.379405,
"sma50": 36.596762000000005,
"sma200": 30.8518905,
"adx": 18.54021140042724,
"atr": 1.12,
"atr_pct": 3.25,
"atr_expansion_pct": -6.8,
"di_plus": 13.3,
"di_minus": 31.8,
"high_52w": 41.81,
"low_52w": 16.03,
"structure": {
"ema8": 34.30879648880087,
"ema21": 35.33234465410862,
"ema50": 35.74173384041925,
"ema200": 30.830071607338606,
"ema10": 34.480627458539665,
"ema20": 35.27436024564689,
"ema10_slope_pct": -2.83,
"ema20_slope_pct": -2.55,
"trend_dir": "down",
"checks": {
"price_above_all": false,
"ema_stacked": false,
"ema21_rising": false,
"ema50_rising": false,
"adx_over_30": false,
"higher_highs_lows": false,
"lower_highs_lows": true,
"near_21ema": false
},
"dist_21ema_pct": -2.3,
"_no_bars": false,
"macd": {
"macd": -0.902,
"signal": -0.737,
"histogram": -0.165
},
"bollinger": {
"mid": 35.38,
"upper": 37.91,
"lower": 32.85,
"width_pct": 14.3
},
"crossover": {
"fresh_cross": null,
"pre_compressed": null,
"held_above_21": null,
"candles_since": null,
"intraday_support": false
},
"momentum": {
"roc10": -3.6,
"ret_3d": 2.64,
"ret_5d": -0.24,
"roc10_accel": 2.91,
"checks": {
"roc_over_5": false,
"rsi_in_band": false,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 0.34,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": false,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": false
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 6.34,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": false,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"mcap_2b_to_200b": true,
"dollar_vol_over_10m": true,
"common_stock": true,
"no_earnings_7d": true
},
"avg_dollar_vol": 233168475.84
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.0,
"iv_rank": 86.0
}
}
}
}
Data:
{
"prior_day": {
"high": 34.59,
"low": 33.6,
"close": 34.52,
"date": "2026-10-19"
},
"woodie_pivots": {
"PP": 34.31,
"R1": 35.02,
"S1": 34.03,
"R2": 35.29,
"S2": 33.32
},
"swing": {
"high_20d": 39.17,
"low_20d": 33,
"high_60d": 42.5,
"low_60d": 32.47
},
"orb": {
"high": 34.36,
"low": 33.7,
"date": "2026-10-19"
},
"vwap": 34.17,
"volume_profile": {
"poc": 35.8,
"vah": 37.2,
"val": 34.2,
"sessions": 20
},
"intraday": {
"h1_trend": "up",
"h1_last": 34.4,
"h1_ema9": 33.93,
"h1_ema21": 33.91,
"m15_trend": "up",
"m15_last": 34.55,
"m15_ema9": 34.24,
"m15_ema21": 33.99,
"rvol_intraday": 1.19,
"as_of_et": "2026-10-19 12:25"
},
"premarket": {
"date": "2026-10-19",
"high": 34,
"low": 33.67,
"last": 33.67,
"volume": 15336,
"gap_pct": 0.42,
"path": "06:55 33.68 -> 07:00 33.90 -> 07:05 33.79 -> 07:10 33.70 -> 09:00 33.95 -> 09:05 33.85 -> 09:20 33.67",
"bars": 7,
"last_bar_et": "09:20"
},
"recent_daily": [
{
"d": "2026-09-15",
"o": 41.14,
"h": 41.14,
"l": 39.215,
"c": 39.5,
"v": 8104986.187922
},
{
"d": "2026-09-16",
"o": 39.77,
"h": 40.445,
"l": 39.165,
"c": 39.57,
"v": 6181218.225582
},
{
"d": "2026-09-17",
"o": 40.445,
"h": 40.97,
"l": 39.5,
"c": 39.98,
"v": 7603981.304849
},
{
"d": "2026-09-18",
"o": 40.11,
"h": 40.71,
"l": 39.715,
"c": 39.77,
"v": 32200465.111081
},
{
"d": "2026-09-21",
"o": 39.02,
"h": 39.9,
"l": 38.72,
"c": 38.99,
"v": 5620750.911972
},
{
"d": "2026-09-22",
"o": 38.73,
"h": 39.17,
"l": 38.11,
"c": 38.22,
"v": 6752768.971319
},
{
"d": "2026-09-23",
"o": 38,
"h": 38.47,
"l": 36.78,
"c": 36.82,
"v": 9272934.45361
},
{
"d": "2026-09-24",
"o": 36.64,
"h": 36.75,
"l": 35.905,
"c": 36.13,
"v": 5659882.350176
},
{
"d": "2026-09-25",
"o": 35.98,
"h": 36.19,
"l": 35.515,
"c": 35.8,
"v": 6764455.637294
},
{
"d": "2026-09-28",
"o": 35.65,
"h": 37.245,
"l": 35.28,
"c": 36.98,
"v": 6972000.613376
},
{
"d": "2026-09-29",
"o": 37.03,
"h": 37.345,
"l": 35.75,
"c": 36.5,
"v": 6587918.80828
},
{
"d": "2026-09-30",
"o": 36.77,
"h": 36.955,
"l": 36.23,
"c": 36.57,
"v": 5282356.761857
},
{
"d": "2026-10-01",
"o": 36.35,
"h": 36.79,
"l": 35.435,
"c": 35.5,
"v": 3271968.923813
},
{
"d": "2026-10-02",
"o": 35.61,
"h": 36,
"l": 35.19,
"c": 35.72,
"v": 4365824.833916
},
{
"d": "2026-10-05",
"o": 35.98,
"h": 36.325,
"l": 35.245,
"c": 35.78,
"v": 6201635.000364
},
{
"d": "2026-10-06",
"o": 35.86,
"h": 36.34,
"l": 34.75,
"c": 35.53,
"v": 5739959.620542
},
{
"d": "2026-10-07",
"o": 35.22,
"h": 35.485,
"l": 34.63,
"c": 34.75,
"v": 5740295.276871
},
{
"d": "2026-10-08",
"o": 34.275,
"h": 34.56,
"l": 33.32,
"c": 34.21,
"v": 6403946.122189
},
{
"d": "2026-10-09",
"o": 34.24,
"h": 35.59,
"l": 34.15,
"c": 35.44,
"v": 5533163.501169
},
{
"d": "2026-10-12",
"o": 34.92,
"h": 35.41,
"l": 34.55,
"c": 34.59,
"v": 4734664.713469
},
{
"d": "2026-10-13",
"o": 34.44,
"h": 34.915,
"l": 33.26,
"c": 33.35,
"v": 6322225.818123
},
{
"d": "2026-10-14",
"o": 33.14,
"h": 34.09,
"l": 33,
"c": 33.62,
"v": 4293777.076737
},
{
"d": "2026-10-15",
"o": 33.82,
"h": 34.355,
"l": 33.7,
"c": 34.04,
"v": 4565910.620315
},
{
"d": "2026-10-16",
"o": 34.12,
"h": 34.12,
"l": 33.23,
"c": 33.53,
"v": 4923609.711055
},
{
"d": "2026-10-19",
"o": 33.78,
"h": 34.585,
"l": 33.6,
"c": 34.525,
"v": 1897560.021862
}
]
}
Data:
{
"sector": "Healthcare",
"etf": "XLV",
"etf_trend": "up",
"etf_r5d": 2.02,
"etf_rvol": 0.43,
"rs_5d": -2.21,
"leading": false
}
Data:
{
"estimates": [
{
"symbol": "ROIV",
"date": "2031-03-31",
"revenueLow": 2785687451,
"revenueHigh": 8090437415,
"revenueAvg": 5496988800,
"ebitdaLow": 1624850128,
"ebitdaHigh": 4771261316,
"ebitdaAvg": 3233010606,
"ebitLow": 911458803,
"ebitHigh": 4057869991,
"ebitAvg": 2519619281,
"netIncomeLow": 741387312,
"netIncomeHigh": 3333672139,
"netIncomeAvg": 2066328573,
"sgaExpenseLow": 74190236641,
"sgaExpenseHigh": 215469781485,
"sgaExpenseAvg": 146399374323,
"epsAvg": 2.978,
"epsHigh": 4.8045,
"epsLow": 1.06849,
"numAnalystsRevenue": 4,
"numAnalystsEps": 2
},
{
"symbol": "ROIV",
"date": "2030-03-31",
"revenueLow": 1665283499,
"revenueHigh": 4836462155,
"revenueAvg": 3286099000,
"ebitdaLow": 782066702,
"ebitdaHigh": 2195733000,
"ebitdaAvg": 1504602388,
"ebitLow": 415900368,
"ebitHigh": 1829566666,
"ebitAvg": 1138436054,
"netIncomeLow": 333103545,
"netIncomeHigh": 1497803731,
"netIncomeAvg": 928390742,
"sgaExpenseLow": 44350911234,
"sgaExpenseHigh": 128807799905,
"sgaExpenseAvg": 87517521877,
"epsAvg": 1.338,
"epsHigh": 2.15864,
"epsLow": 0.48007,
"numAnalystsRevenue": 3,
"numAnalystsEps": 1
},
{
"symbol": "ROIV",
"date": "2029-03-31",
"revenueLow": 997386803,
"revenueHigh": 2132453816,
"revenueAvg": 1494699878,
"ebitdaLow": -779917787,
"ebitdaHigh": 1037815646,
"ebitdaAvg": -69237541,
"ebitLow": -923438359,
"ebitHigh": 894295075,
"ebitAvg": -212758113,
"netIncomeLow": -935031026,
"netIncomeHigh": 727246353,
"netIncomeAvg": -224350780,
"sgaExpenseLow": 26563052833,
"sgaExpenseHigh": 56792894400,
"sgaExpenseAvg": 39807817498,
"epsAvg": -0.45443,
"epsHigh": 1.04811,
"epsLow": -1.34757,
"numAnalystsRevenue": 7,
"numAnalystsEps": 5
},
{
"symbol": "ROIV",
"date": "2028-03-31",
"revenueLow": 181783846,
"revenueHigh": 570040222,
"revenueAvg": 407381160,
"ebitdaLow": -1417455460,
"ebitdaHigh": -277845416,
"ebitdaAvg": -943859620,
"ebitLow": -1453946363,
"ebitHigh": -314336319,
"ebitAvg": -980350523,
"netIncomeLow": -1465539030,
"netIncomeHigh": -325928986,
"netIncomeAvg": -991943190,
"sgaExpenseLow": 4841385399,
"sgaExpenseHigh": 15181681257,
"sgaExpenseAvg": 10849639521,
"epsAvg": -1.30918,
"epsHigh": -0.46973,
"epsLow": -2.11214,
"numAnalystsRevenue": 9,
"numAnalystsEps": 4
}
],
"price_target": {
"symbol": "ROIV",
"targetHigh": 55,
"targetLow": 41,
"targetConsensus": 47.71,
"targetMedian": 47
},
"ratings": {
"symbol": "ROIV",
"rating": "C",
"overallScore": 2,
"discountedCashFlowScore": 2,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 4,
"priceToEarningsScore": 1,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "ROIV",
"date": "2026-10-12",
"gradingCompany": "Wolfe Research",
"previousGrade": "Outperform",
"newGrade": "Peer Perform",
"action": "downgrade"
},
{
"symbol": "ROIV",
"date": "2026-09-09",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2026-09-09",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2026-09-08",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2026-09-08",
"gradingCompany": "Jefferies",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2026-08-28",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2026-08-10",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2026-08-07",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2026-08-07",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2026-05-26",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2026-05-21",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2026-05-21",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2026-05-21",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2026-04-16",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2026-03-04",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2026-02-10",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2026-02-10",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2026-02-09",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2025-12-15",
"gradingCompany": "Goldman Sachs",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2025-12-15",
"gradingCompany": "Leerink Partners",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2025-12-12",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2025-11-11",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ROIV",
"date": "2025-10-29",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Roivant Sciences Ltd. $ROIV Stock Holdings Lowered by Assenagon Asset Management S.A.",
"url": "https://www.defenseworld.net/2026/10/16/roivant-sciences-ltd-roiv-stock-holdings-lowered-by-assenagon-asset-management-s-a.html",
"source": "Defense World",
"date": "2026-10-16 03:47:34",
"summary": "Assenagon Asset Management S.A. lessened its holdings in shares of Roivant Sciences Ltd. (NASDAQ: ROIV) by 11.7% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,382,971 shares of the company's stock a",
"image": "https://images.financialmodelingprep.com/news/roivant-sciences-ltd-roiv-stock-holdings-lowered-by-assenagon-20261016.jpg"
},
{
"title": "Head-To-Head Review: Janux Therapeutics (NASDAQ:JANX) and Roivant Sciences (NASDAQ:ROIV)",
"url": "https://www.defenseworld.net/2026/10/06/head-to-head-review-janux-therapeutics-nasdaqjanx-and-roivant-sciences-nasdaqroiv.html",
"source": "Defense World",
"date": "2026-10-06 06:15:24",
"summary": "Janux Therapeutics (NASDAQ: JANX - Get Free Report) and Roivant Sciences (NASDAQ: ROIV - Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, analyst reco",
"image": "https://images.financialmodelingprep.com/news/headtohead-review-janux-therapeutics-nasdaqjanx-and-roivant-sciences-nasdaqroiv-20261006.png"
},
{
"title": "Roivant\u2019s Eric Venker sells 200,000 shares after option exercise (NASDAQ: ROIV)",
"url": "https://www.defenseworld.net/2026/10/04/roivants-eric-venker-sells-200000-shares-after-option-exercise-nasdaq-roiv.html",
"source": "Defense World",
"date": "2026-10-04 09:02:54",
"summary": "What happened Roivant Sciences Ltd. (NASDAQ: ROIV) said Eric Venker, its president and Immunovant CEO, exercised options for 200,000 shares and sold 200,000 shares on 2026-09-30. The shares sold at a weighted average $36.62 each, within a reported range of $36.49 to $36.76, for a",
"image": "https://images.financialmodelingprep.com/news/roivants-eric-venker-sells-200000-shares-after-option-exercise-20261004.jpg"
},
{
"title": "Roivant Sciences Targets LISRAYA Launch, Key Pipeline Readouts in Next 12 Months",
"url": "https://www.defenseworld.net/2026/09/28/roivant-sciences-targets-lisraya-launch-key-pipeline-readouts-in-next-12-months.html",
"source": "Defense World",
"date": "2026-09-28 04:02:54",
"summary": "Roivant Sciences (NASDAQ: ROIV) CEO Matthew Gline outlined the company's priorities for the next 12 months, including the launch of LISRAYA, upcoming clinical data for brepocitinib and Immunovant's IMVT-1402, and expansion of its pulmonary hypertension program. Gline said Roivant",
"image": "https://images.financialmodelingprep.com/news/roivant-sciences-targets-lisraya-launch-key-pipeline-readouts-in-next-20260928.jpg"
},
{
"title": "Stock Analyst Ratings: Upgrades and Downgrades - Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/cantor-fitzgerald-reiterates-roivant-sciences-stock-rating-93CH-4915189",
"source": "Investing.com",
"date": "2026-09-24T11:50:45Z",
"summary": "Investing.com - Cantor Fitzgerald reiterated an Overweight rating on Roivant Sciences (NASDAQ:ROIV). The stock has surged 150% over the past year to a current price of $36.82, with analysts maintaining a Strong Buy consensus and price targets ranging from $41 to $55.\n\nThe firm co",
"image": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png"
},
{
"title": "Roivant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus",
"url": "https://www.globenewswire.com/news-release/2026/09/23/3367356/34323/en/roivant-announces-topline-results-from-proof-of-concept-study-of-imvt-1402-in-cutaneous-lupus-erythematosus.html",
"source": "GlobeNewsWire",
"date": "2026-09-23 07:00:00",
"summary": "Immunovant's proof-of-concept study of IMVT-1402 (imeroprubart) in cutaneous lupus erythematosus (CLE) did not achieve statistical significance on the primary endpoint of Cutaneous Lupus Erythematosus Disease Area and Severity Index Activity (CLASI-A) percent change from baseline",
"image": "https://images.financialmodelingprep.com/news/roivant-announces-topline-results-from-proofofconcept-study-of-imvt1402-20260923.jpg"
},
{
"title": "Immunovant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus",
"url": "https://www.globenewswire.com/news-release/2026/09/23/3367346/0/en/immunovant-announces-topline-results-from-proof-of-concept-study-of-imvt-1402-in-cutaneous-lupus-erythematosus.html",
"source": "GlobeNewsWire",
"date": "2026-09-23 07:00:00",
"summary": "Immunovant's proof-of-concept study of IMVT-1402 (imeroprubart) in cutaneous lupus erythematosus (CLE) did not achieve statistical significance on the primary endpoint of Cutaneous Lupus Erythematosus Disease Area and Severity Index Activity (CLASI-A) percent change from baseline",
"image": "https://images.financialmodelingprep.com/news/immunovant-announces-topline-results-from-proofofconcept-study-of-imvt1402-20260923.jpg"
},
{
"title": "Roivant at Bank of America Global Healthcare Conference: pipeline momentum builds By Investing.com",
"url": "https://www.investing.com/news/transcripts/roivant-at-bank-of-america-global-healthcare-conference-pipeline-momentum-builds-93CH-4910971",
"source": "Investing.com",
"date": "2026-09-22T13:09:53Z",
"summary": "Tuesday, 22 September 2026 -- Roivant Sciences (ROIV) used the Bank of America Global Healthcare Conference to outline a pipeline that management says has gained momentum across commercial, clinical and strategic fronts. CEO Matt Gline pointed to the recent approval of brepocitin",
"image": "https://content-media.investing.com/news/LYNXNPEC0K08U_L.jpg"
},
{
"title": "Roivant (ROIV): $9 Billion Sales Potential Faces a Commercialization Test",
"url": "https://finance.yahoo.com/healthcare/articles/roivant-roiv-9-billion-sales-102730498.html",
"source": "Yahoo! Finance",
"date": "2026-09-22T10:27:30Z",
"summary": "Roivant Sciences Ltd. (NASDAQ:ROIV) may be entering the most important phase of its business, as its pipeline begins to move from clinical development to commercialization.\n\nStifel initiated coverage of Roivant with a Buy rating and a $51 price target on September 16. The target ",
"image": "https://s.yimg.com/lo/mysterio/api/8d8223c993f500bc0133bf1d4461007fb8b0ad68ce23f9f1eb0888840d1d70b0/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Finsidermonkey.com%2F43bf23345f4a2722434737f4333e06f5.jpg"
},
{
"title": "Roivant Sciences Ltd. (ROIV) Presents at Bank of America Global Healthcare Conference 2026 Transcript",
"url": "https://seekingalpha.com/article/4948644-roivant-sciences-ltd-roiv-presents-at-bank-of-america-global-healthcare-conference-2026",
"source": "Seeking Alpha",
"date": "2026-09-22 14:29:55",
"summary": "Roivant Sciences Ltd. (ROIV) Presents at Bank of America Global Healthcare Conference 2026 Transcript",
"image": "https://images.financialmodelingprep.com/news/roivant-sciences-ltd-roiv-presents-at-bank-of-america-20260922.jpg"
},
{
"title": "Insider Selling: Roivant Sciences (NASDAQ:ROIV) Director Sells $196,236.12 in Stock",
"url": "https://www.defenseworld.net/2026/09/20/insider-selling-roivant-sciences-nasdaqroiv-director-sells-196236-12-in-stock.html",
"source": "Defense World",
"date": "2026-09-20 05:09:11",
"summary": "Roivant Sciences Ltd. (NASDAQ: ROIV - Get Free Report) Director Melissa Epperly sold 4,938 shares of the stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $39.74, for a total value of $196,236.12. Following the completion of the transa",
"image": "https://images.financialmodelingprep.com/news/insider-selling-roivant-sciences-nasdaqroiv-director-sells-19623612-in-20260920.jpg"
},
{
"title": "Here are Thursday's biggest analyst calls: Apple, Nvidia, Tesla, Alphabet, Kraft Heinz, Lyft, Palo Alto & more",
"url": "https://www.cnbc.com/2026/09/17/thursday-biggest-analyst-calls.html",
"source": "CNBC",
"date": "2026-09-17T12:14:23Z",
"summary": "Here are Thursday's biggest calls on Wall Street: Goldman Sachs upgrades Sunbelt to buy from neutral Goldman said it sees \"growth improvement.\" \"Our upgrade follows the strong 1Q27 results, which saw the company deliver results ahead of consensus while raising its FY outlook. SUN",
"image": "https://image.cnbcfm.com/api/v1/image/108229168-17636514422025-10-28t100019z_1226650128_rc2z28a7uakr_rtrmadp_0_nvidia-developers.jpeg?v=1764596799&w=1920&h=1080"
},
{
"title": "Stifel initiates Roivant Sciences stock with buy rating, $51 target By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/stifel-initiates-roivant-sciences-stock-with-buy-rating-51-target-93CH-4904559",
"source": "Investing.com",
"date": "2026-09-16T20:52:45Z",
"summary": "Investing.com - Stifel initiated coverage on Roivant Sciences Ltd (NASDAQ:ROIV) with a buy rating and a price target of $51.00, the firm said Tuesday. The stock currently trades at $39.57, representing roughly 29% upside to Stifel's target. Shares have surged 178% over the past y",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM3S10Z_1200_L.jpg"
},
{
"title": "Roivant Sciences Ltd. (ROIV)'s Pulmonary Hypertension Breakthrough Could Transform Its Growth Story",
"url": "https://finance.yahoo.com/healthcare/articles/roivant-sciences-ltd-roiv-pulmonary-094515386.html",
"source": "Yahoo! Finance",
"date": "2026-09-13T09:45:15Z",
"summary": "Roivant Sciences Ltd. (NASDAQ:ROIV) shares surged 18% on September 8 after the biotech company reported strong Phase 2 results for an experimental treatment for pulmonary hypertension. The positive topline results from the Phase 2 PHocus trial of Mosliciguat provide an important ",
"image": "https://s.yimg.com/lo/mysterio/api/b21325e464ae21ef3d398b6350ef1e63e22a59bbd6d248e2cd24a4e38ba75e2c/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Finsidermonkey.com%2F7c16cc3bd8d9db40639fe719e3997005.jpg"
},
{
"title": "Roivant Sciences: Diverse Exposure To Biotech Niches Through Vants",
"url": "https://seekingalpha.com/article/4945843-roivant-sciences-diverse-exposure-to-biotech-niches-through-vants",
"source": "Seeking Alpha",
"date": "2026-09-13 07:30:08",
"summary": "LISRAYA's recent approval gives ROIV a nice commercial foundation, while additional indications could turn brepocitinib into a broader immunology franchise. ROIV's pulmonary asset with mosliciguat is also promising. This candidate may be helpful for vascular resistance and walkin",
"image": "https://images.financialmodelingprep.com/news/roivant-sciences-diverse-exposure-to-biotech-niches-through-vants-20260913.jpg"
},
{
"title": "Roivant Sciences Ltd. (ROIV) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript",
"url": "https://seekingalpha.com/article/4945113-roivant-sciences-ltd-roiv-presents-at-citigroups-biopharma-back-to-school-summit-2026",
"source": "Seeking Alpha",
"date": "2026-09-10 17:07:09",
"summary": "Roivant Sciences Ltd. (ROIV) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript",
"image": "https://images.financialmodelingprep.com/news/roivant-sciences-ltd-roiv-presents-at-citigroups-biopharma-back-20260910.jpg"
},
{
"title": "Roivant at Cantor conference: pipeline gains momentum after mosliciguat data By Investing.com",
"url": "https://www.investing.com/news/transcripts/roivant-at-cantor-conference-pipeline-gains-momentum-after-mosliciguat-data-93CH-4894325",
"source": "Investing.com",
"date": "2026-09-09T18:17:44Z",
"summary": "Wednesday, 09 September 2026 -- Roivant Sciences (ROIV) used the 12th Annual Cantor Fitzgerald Global Healthcare Conference to highlight a series of clinical and strategic advances, led by unusually strong data for mosliciguat and an early launch for brepocitinib in dermatomyosit",
"image": "https://content-media.investing.com/news/LYNXNPEC0L0PD_L.jpg"
},
{
"title": "Company News for Sep 9, 2026",
"url": "https://finance.yahoo.com/markets/stocks/articles/company-news-sep-9-2026-111500913.html",
"source": "Yahoo! Finance",
"date": "2026-09-09T11:15:00Z",
"summary": "* QUALCOMM Incorporated (QCOM) shares rose 3.2% on optimism over its new data center partnership with Amazon Web Services and its AI growth prospects.\n\n* Roivant Sciences Ltd. (ROIV) shares surged18.8% after positive Phase 2 results for its pulmonary hypertension drug candidate m",
"image": "https://s.yimg.com/lo/mysterio/api/875aa7d558f23ab8cf65cb9d471682e2b47b326838dbf866d297666a4fd06e86/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fzacks.com%2Fddf3924b1ec6dc1f7af2495f083fa70e.jpg"
},
{
"title": "TD Cowen raises Roivant Sciences stock price target on trial data By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/td-cowen-raises-roivant-sciences-stock-price-target-on-trial-data-93CH-4893134",
"source": "Investing.com",
"date": "2026-09-09T10:29:03Z",
"summary": "Investing.com - TD Cowen raised its price target on Roivant Sciences (NASDAQ:ROIV) to $55 from $50 while maintaining a Buy rating on the stock. The stock currently trades at $41.48, near its 52-week high of $42.50, following a remarkable 208% gain over the past year.\n\nThe firm ci",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM450ND_1200_L.jpg"
},
{
"title": "Roivant (ROIV) Soars to All-Time High; Q2 Hedge Fund Holdings Surge 41%",
"url": "https://finance.yahoo.com/healthcare/articles/roivant-roiv-soars-time-high-014015128.html",
"source": "Yahoo! Finance",
"date": "2026-09-09T01:40:15Z",
"summary": "Roivant Sciences Ltd. (NASDAQ:ROIV) soared to a new all-time high on Tuesday after reporting stellar results from the clinical trial of its treatment candidate for pulmonary hypertension associated with interstitial lung disease (PH-ILD).\n\nIn intra-day trading, the stock jumped t",
"image": "https://s.yimg.com/lo/mysterio/api/4d602c91a9c79c22f58eb42c49e99f4c049b1c8ba40ca9b27d4473eda52a75d9/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Finsidermonkey.com%2Fe7fe311f61ac083252e765e726938727.jpg"
},
{
"title": "Roivant Sciences Ltd. (ROIV) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript",
"url": "https://seekingalpha.com/article/4944573-roivant-sciences-ltd-roiv-presents-at-12th-annual-cantor-fitzgerald-global-healthcare",
"source": "Seeking Alpha",
"date": "2026-09-09 15:57:12",
"summary": "Roivant Sciences Ltd. (ROIV) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript",
"image": "https://images.financialmodelingprep.com/news/roivant-sciences-ltd-roiv-presents-at-12th-annual-cantor-20260909.jpg"
},
{
"title": "Jefferies raises Roivant Sciences stock price target on trial data By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/jefferies-raises-roivant-sciences-stock-price-target-on-trial-data-93CH-4892063",
"source": "Investing.com",
"date": "2026-09-08T15:42:52Z",
"summary": "Investing.com - Jefferies raised its price target on Roivant Sciences (NASDAQ:ROIV) shares to $52 from $42 while maintaining a Buy rating. The stock currently trades at $41.22, up 171% over the past year and trading near its 52-week high. According to InvestingPro analysis, the c",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM4519D_1200_L.jpg"
},
{
"title": "Roivant at Wells Fargo conference: pipeline momentum lifts outlook By Investing.com",
"url": "https://www.investing.com/news/transcripts/roivant-at-wells-fargo-conference-pipeline-momentum-lifts-outlook-93CH-4892018",
"source": "Investing.com",
"date": "2026-09-08T15:01:18Z",
"summary": "Tuesday, 08 September 2026 -- Roivant Sciences used the Wells Fargo 21st Annual Healthcare Conference to highlight a pipeline that is moving on several fronts at once, from a newly approved drug in dermatomyositis to promising late-stage plans in pulmonary hypertension and autoim",
"image": "https://content-media.investing.com/news/LYNXNPEB8506G_L.jpg"
},
{
"title": "Dr. Gillian Cannon Joins Lindus Therapeutics\u2019 Board as a Non-Executive Director",
"url": "https://www.globenewswire.com/news-release/2026/09/08/3357552/0/en/dr-gillian-cannon-joins-lindus-therapeutics-board-as-a-non-executive-director.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-08T12:00:00Z",
"summary": "Lindus Therapeutics, a drug development company focused on in-licensed assets, has appointed Dr. Gillian Cannon as a non-executive director. Cannon brings over 30 years of biopharmaceutical commercial leadership experience from roles at Merck and Roivant Sciences. She will help s",
"image": "https://www.globenewswire.com/news-release/2026/09/08/3357552/0/en/dr-gillian-cannon-joins-lindus-therapeutics-board-as-a-non-executive-director.html"
},
{
"title": "Roivant's experimental lung disease drug meets goals in mid-stage study",
"url": "https://www.reuters.com/business/healthcare-pharmaceuticals/roivants-experimental-lung-disease-drug-meets-goals-mid-stage-study-2026-09-08/",
"source": "Reuters",
"date": "2026-09-08T11:00:37Z",
"summary": "Sept 8 (Reuters) - Roivant (ROIV.O), opens new tab said on Tuesday its experimental drug met the main goals of a mid-stage study in patients with high blood pressure associated with a type of lung disease, sending shares up about 20% in premarket trading.\n\nRoivant has been expand",
"image": "https://www.reuters.com/resizer/v2/UPWWXXGZ3ZDL5M4W66EWOZVRKM.png?auth=ba7701b661297d5d41b0a5a31a96de94084a623f7ecd4feed0180a877b985a8e&height=1005&width=1920&quality=80&smart=true"
}
]
Data:
[
{
"symbol": "ROIV",
"date": "2026-11-09",
"epsActual": null,
"epsEstimated": -0.36713,
"revenueActual": null,
"revenueEstimated": 3736027,
"lastUpdated": "2026-10-19"
},
{
"symbol": "ROIV",
"date": "2026-08-06",
"epsActual": -0.33,
"epsEstimated": -0.29962,
"revenueActual": 1442000,
"revenueEstimated": 2056750,
"lastUpdated": "2026-10-19"
},
{
"symbol": "ROIV",
"date": "2026-05-20",
"epsActual": -0.2792,
"epsEstimated": -0.28931,
"revenueActual": 2520000,
"revenueEstimated": 3414455,
"lastUpdated": "2026-08-20"
},
{
"symbol": "ROIV",
"date": "2026-02-06",
"epsActual": -0.24,
"epsEstimated": -0.29954,
"revenueActual": 1999000,
"revenueEstimated": 5079500,
"lastUpdated": "2026-07-07"
},
{
"symbol": "ROIV",
"date": "2025-11-10",
"epsActual": -0.20193,
"epsEstimated": -0.3198,
"revenueActual": 1571000,
"revenueEstimated": 5619467,
"lastUpdated": "2026-07-07"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "ROIV",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "ROIV",
"periods": [
{
"file_period": "202608b",
"settlement_date": "20260821",
"quantity_fails": 2028,
"price": 36.84
},
{
"file_period": "202609a",
"settlement_date": "20260911",
"quantity_fails": 5306,
"price": 40.94
},
{
"file_period": "202609b",
"settlement_date": "20260928",
"quantity_fails": 719,
"price": 35.8
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "ROIV",
"filingDate": "2026-10-05",
"transactionDate": "2026-10-01",
"reportingCik": "0001807359",
"companyCik": "0001635088",
"transactionType": "M-Exempt",
"securitiesOwned": 151416,
"reportingName": "Epperly Melissa B,",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 17750,
"price": 4.46,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1635088/000180735926000018/0001807359-26-000018-index.htm"
},
{
"symbol": "ROIV",
"filingDate": "2026-10-05",
"transactionDate": "2026-10-01",
"reportingCik": "0001807359",
"companyCik": "0001635088",
"transactionType": "M-Exempt",
"securitiesOwned": 32704,
"reportingName": "Epperly Melissa B,",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 17750,
"price": 4.46,
"securityName": "Common Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1635088/000180735926000018/0001807359-26-000018-index.htm"
},
{
"symbol": "ROIV",
"filingDate": "2026-10-05",
"transactionDate": "2026-10-01",
"reportingCik": "0001807359",
"companyCik": "0001635088",
"transactionType": "S-Sale",
"securitiesOwned": 15854,
"reportingName": "Epperly Melissa B,",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 16850,
"price": 36.08,
"securityName": "Common Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1635088/000180735926000018/0001807359-26-000018-index.htm"
},
{
"symbol": "ROIV",
"filingDate": "2026-10-05",
"transactionDate": "2026-10-01",
"reportingCik": "0001807359",
"companyCik": "0001635088",
"transactionType": "S-Sale",
"securitiesOwned": 14954,
"reportingName": "Epperly Melissa B,",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 900,
"price": 36.57,
"securityName": "Common Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1635088/000180735926000018/0001807359-26-000018-index.htm"
},
{
"symbol": "ROIV",
"filingDate": "2026-10-02",
"transactionDate": "2026-09-30",
"reportingCik": "0001750094",
"companyCik": "0001635088",
"transactionType": "F-InKind",
"securitiesOwned": 16583774,
"reportingName": "Gline Matthew",
"typeOfOwner": "director, officer: CEO",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 76171,
"price": 36.57,
"securityName": "Common Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1635088/000114036126038475/0001140361-26-038475-index.htm"
},
{
"symbol": "ROIV",
"filingDate": "2026-10-02",
"transactionDate": "2026-09-30",
"reportingCik": "0001647805",
"companyCik": "0001635088",
"transactionType": "F-InKind",
"securitiesOwned": 13495893,
"reportingName": "Torti Frank",
"typeOfOwner": "officer: President and Vant Chair",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 40309,
"price": 36.57,
"securityName": "Common Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1635088/000114036126038474/0001140361-26-038474-index.htm"
},
{
"symbol": "ROIV",
"filingDate": "2026-10-02",
"transactionDate": "2026-09-30",
"reportingCik": "0001750050",
"companyCik": "0001635088",
"transactionType": "F-InKind",
"securitiesOwned": 18583860,
"reportingName": "Sukhatme Mayukh",
"typeOfOwner": "director, officer: President & CIO",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 46879,
"price": 36.57,
"securityName": "Common Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1635088/000163508826000109/0001635088-26-000109-index.htm"
},
{
"symbol": "ROIV",
"filingDate": "2026-10-02",
"transactionDate": "2026-09-30",
"reportingCik": "0001801917",
"companyCik": "0001635088",
"transactionType": "M-Exempt",
"securitiesOwned": 3644834,
"reportingName": "Venker Eric",
"typeOfOwner": "officer: President & Immunovant CEO",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 200000,
"price": 3.85,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1635088/000163508826000108/0001635088-26-000108-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
{
"symbol": "ROIV",
"senateID": "M001136",
"disclosureDate": "2025-11-24",
"transactionDate": "2025-10-31",
"firstName": "Lisa C.",
"lastName": "McClain",
"office": "Lisa McClain",
"district": "MI09",
"owner": "Spouse",
"assetDescription": "Roivant Sciences Ltd. - Common Shares",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20033446.pdf"
},
{
"symbol": "ROIV",
"senateID": "M001136",
"disclosureDate": "2025-11-24",
"transactionDate": "2025-10-30",
"firstName": "Lisa C.",
"lastName": "McClain",
"office": "Lisa McClain",
"district": "MI09",
"owner": "Spouse",
"assetDescription": "Roivant Sciences Ltd. - Common Shares",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20033446.pdf"
},
{
"symbol": "ROIV",
"senateID": "M001136",
"disclosureDate": "2025-11-24",
"transactionDate": "2025-10-30",
"firstName": "Lisa C.",
"lastName": "McClain",
"office": "Lisa McClain",
"district": "MI09",
"owner": "Spouse",
"assetDescription": "Roivant Sciences Ltd. - Common Shares",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20033446.pdf"
},
{
"symbol": "ROIV",
"senateID": "M001136",
"disclosureDate": "2025-08-13",
"transactionDate": "2025-06-17",
"firstName": "Lisa C.",
"lastName": "McClain",
"office": "Lisa McClain",
"district": "MI09",
"owner": "Spouse",
"assetDescription": "Roivant Sciences Ltd. - Common Shares",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030891.pdf"
}
],
"dark_pool": [
{
"ticker": "ROIV",
"executed_at": "2026-10-19T15:49:50.564000Z",
"size": 600.0,
"price": 34.41,
"premium": 20645.999999999996,
"volume": 600.0,
"trade_code": "F"
},
{
"ticker": "ROIV",
"executed_at": "2026-10-19T15:48:49.598000Z",
"size": 535.0,
"price": 34.41,
"premium": 18409.35,
"volume": 535.0,
"trade_code": " "
},
{
"ticker": "ROIV",
"executed_at": "2026-10-19T15:50:01.073000Z",
"size": 469.0,
"price": 34.41,
"premium": 16138.289999999999,
"volume": 469.0,
"trade_code": " "
},
{
"ticker": "ROIV",
"executed_at": "2026-10-19T15:50:01.073000Z",
"size": 400.0,
"price": 34.41,
"premium": 13763.999999999998,
"volume": 400.0,
"trade_code": " "
},
{
"ticker": "ROIV",
"executed_at": "2026-10-19T15:49:50.564000Z",
"size": 400.0,
"price": 34.41,
"premium": 13763.999999999998,
"volume": 400.0,
"trade_code": "F"
},
{
"ticker": "ROIV",
"executed_at": "2026-10-19T15:49:44.524000Z",
"size": 400.0,
"price": 34.405,
"premium": 13762.0,
"volume": 400.0,
"trade_code": " "
},
{
"ticker": "ROIV",
"executed_at": "2026-10-19T15:48:36.484000Z",
"size": 400.0,
"price": 34.41,
"premium": 13763.999999999998,
"volume": 400.0,
"trade_code": " "
},
{
"ticker": "ROIV",
"executed_at": "2026-10-19T15:50:25.696000Z",
"size": 372.0,
"price": 34.435,
"premium": 12809.820000000002,
"volume": 372.0,
"trade_code": " "
}
],
"ats": {
"symbol": "ROIV",
"date": "20261016",
"ats_volume": 0,
"total_volume": 1768753,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20261016",
"ats_ratio": 0.0
},
{
"date": "20261015",
"ats_ratio": 0.0
},
{
"date": "20261014",
"ats_ratio": 0.0
},
{
"date": "20261013",
"ats_ratio": 0.0
},
{
"date": "20261012",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "ROIV",
"days": [
{
"date": "2026-10-19",
"close": 34.525,
"vwap": 34.13,
"volume": 1897560,
"vwap_discount_pct": -1.14
},
{
"date": "2026-10-16",
"close": 33.53,
"vwap": 33.51,
"volume": 4923609,
"vwap_discount_pct": -0.06
},
{
"date": "2026-10-15",
"close": 34.04,
"vwap": 34.06,
"volume": 4565910,
"vwap_discount_pct": 0.06
},
{
"date": "2026-10-14",
"close": 33.62,
"vwap": 33.64,
"volume": 4293777,
"vwap_discount_pct": 0.05
},
{
"date": "2026-10-13",
"close": 33.35,
"vwap": 33.6,
"volume": 6322225,
"vwap_discount_pct": 0.75
}
],
"avg_vwap_discount_pct": -0.07,
"signal": "Neutral"
},
"options_flow": [],
"net_premium": {
"ticker": "ROIV",
"net_call_premium": "1094.00",
"net_put_premium": "-245.00",
"call_premium": "1684.00",
"put_premium": "245.00",
"bullish_premium": "1634.00",
"bearish_premium": "295.00",
"put_call_ratio": "0.10",
"iv_rank": "86.1094",
"implied_move_perc": "0.125",
"gex_ratio": null,
"gex_net_change": null,
"gex_call": "219065.3183",
"gex_put": "-75155.8581",
"gex_net": 143909.4602,
"gex_call_delta": "1811506.6792",
"gex_put_delta": "-694066.5673",
"gex_date": "2026-10-19"
},
"hot_chains": [
{
"underlying_symbol": "ROIV",
"expires": "2026-11-20",
"open_interest": 4,
"option_type": "call",
"delta": 0.1353144418419162,
"ask_volume": 4,
"last_price": "0.05",
"implied_volatility": "0.605370448330399",
"gamma": 0.02115285953300416,
"avg_price": "0.05",
"bid_volume": 0,
"nbbo_ask": "2.25",
"strike": "50",
"option_symbol": "ROIV261120C00050000",
"total_premium": "20.00",
"iv": 1.005800717208468,
"volume": 4,
"nbbo_bid": "0.05"
},
{
"underlying_symbol": "ROIV",
"expires": "2027-02-19",
"open_interest": 7,
"option_type": "call",
"delta": 0.526270234223779,
"ask_volume": 1,
"last_price": "3.70",
"implied_volatility": "0.49805525659086",
"gamma": 0.0440850359611079,
"avg_price": "3.70",
"bid_volume": 0,
"nbbo_ask": "5.40",
"strike": "35",
"option_symbol": "ROIV270219C00035000",
"total_premium": "370.00",
"iv": 0.451718471039083,
"volume": 1,
"nbbo_bid": "1.05"
},
{
"underlying_symbol": "ROIV",
"expires": "2027-02-19",
"open_interest": 2,
"option_type": "call",
"delta": 0.483695219609943,
"ask_volume": 1,
"last_price": "3.30",
"implied_volatility": "0.49781598114599",
"gamma": 0.0440630547188278,
"avg_price": "3.30",
"bid_volume": 0,
"nbbo_ask": "5.00",
"strike": "36",
"option_symbol": "ROIV270219C00036000",
"total_premium": "330.00",
"iv": 0.452547828394069,
"volume": 1,
"nbbo_bid": "0.65"
},
{
"underlying_symbol": "ROIV",
"expires": "2027-02-19",
"open_interest": 1,
"option_type": "call",
"delta": 0.397843611903695,
"ask_volume": 1,
"last_price": "2.40",
"implied_volatility": "0.470601469228201",
"gamma": 0.0436924224528098,
"avg_price": "2.40",
"bid_volume": 0,
"nbbo_ask": "4.50",
"strike": "38",
"option_symbol": "ROIV270219C00038000",
"total_premium": "240.00",
"iv": 0.441709766638415,
"volume": 1,
"nbbo_bid": "0.20"
},
{
"underlying_symbol": "ROIV",
"expires": "2027-02-19",
"open_interest": 0,
"option_type": "call",
"delta": 0.440795508980072,
"ask_volume": 1,
"last_price": "2.70",
"implied_volatility": "0.48011533896767",
"gamma": 0.0440280268074839,
"avg_price": "2.70",
"bid_volume": 0,
"nbbo_ask": "4.80",
"strike": "37",
"option_symbol": "ROIV270219C00037000",
"total_premium": "270.00",
"iv": 0.448285777140142,
"volume": 1,
"nbbo_bid": "0.50"
},
{
"underlying_symbol": "ROIV",
"expires": "2026-11-20",
"open_interest": 303,
"option_type": "put",
"delta": -0.435072191495665,
"ask_volume": 0,
"last_price": "2.45",
"implied_volatility": "0.58996928993466",
"gamma": 0.0523345561918841,
"avg_price": "2.45",
"bid_volume": 1,
"nbbo_ask": "4.70",
"strike": "34",
"option_symbol": "ROIV261120P00034000",
"total_premium": "245.00",
"iv": 0.735884893638064,
"volume": 1,
"nbbo_bid": "2.45"
},
{
"underlying_symbol": "ROIV",
"expires": "2027-01-15",
"open_interest": 3,
"option_type": "call",
"delta": 0.483498065768814,
"ask_volume": 0,
"last_price": "2.95",
"implied_volatility": "0.515049643269132",
"gamma": 0.0441339411980916,
"avg_price": "2.95",
"bid_volume": 1,
"nbbo_ask": "3.20",
"strike": "36",
"option_symbol": "ROIV270115C00036000",
"total_premium": "295.00",
"iv": 0.533970984533955,
"volume": 1,
"nbbo_bid": "2.80"
},
{
"underlying_symbol": "ROIV",
"expires": "2026-11-20",
"open_interest": 6287,
"option_type": "call",
"delta": 0.35340882578598,
"ask_volume": 1,
"last_price": "1.59",
"implied_volatility": "0.61896911427014",
"gamma": 0.0677319265268877,
"avg_price": "1.59",
"bid_volume": 0,
"nbbo_ask": "1.75",
"strike": "37",
"option_symbol": "ROIV261120C00037000",
"total_premium": "159.00",
"iv": 0.536891908522397,
"volume": 1,
"nbbo_bid": "0.70"
}
],
"gamma_profile": {
"ticker": "ROIV",
"spot": 34.425,
"date": "2026-10-19",
"flip_point": 38.19,
"net_gex": 143909.46,
"call_walls": [
{
"strike": 39.0,
"gex": 71756.18
},
{
"strike": 45.0,
"gex": 55881.94
},
{
"strike": 37.0,
"gex": 41439.82
}
],
"put_walls": [
{
"strike": 32.0,
"gex": -50995.49
},
{
"strike": 40.0,
"gex": -5305.42
},
{
"strike": 38.0,
"gex": -4231.77
}
],
"by_strike": [
{
"strike": 22.0,
"call_gex": 73.81,
"put_gex": -560.57,
"net_gex": -486.76
},
{
"strike": 23.0,
"call_gex": 8.1,
"put_gex": -9.6,
"net_gex": -1.5
},
{
"strike": 24.0,
"call_gex": 0.0,
"put_gex": -10.61,
"net_gex": -10.61
},
{
"strike": 25.0,
"call_gex": 157.27,
"put_gex": -1463.77,
"net_gex": -1306.51
},
{
"strike": 26.0,
"call_gex": 0.0,
"put_gex": -324.71,
"net_gex": -324.71
},
{
"strike": 27.0,
"call_gex": 399.22,
"put_gex": -929.27,
"net_gex": -530.05
},
{
"strike": 28.0,
"call_gex": 936.57,
"put_gex": -922.88,
"net_gex": 13.69
},
{
"strike": 29.0,
"call_gex": 221.25,
"put_gex": -45.85,
"net_gex": 175.4
},
{
"strike": 30.0,
"call_gex": 2513.74,
"put_gex": -2557.04,
"net_gex": -43.3
},
{
"strike": 31.0,
"call_gex": 995.81,
"put_gex": -131.39,
"net_gex": 864.42
},
{
"strike": 32.0,
"call_gex": 1435.02,
"put_gex": -50995.49,
"net_gex": -49560.47
},
{
"strike": 33.0,
"call_gex": 382.85,
"put_gex": -2276.52,
"net_gex": -1893.67
},
{
"strike": 34.0,
"call_gex": 49.58,
"put_gex": -1619.54,
"net_gex": -1569.97
},
{
"strike": 35.0,
"call_gex": 4706.33,
"put_gex": -1185.21,
"net_gex": 3521.12
},
{
"strike": 36.0,
"call_gex": 398.08,
"put_gex": -142.65,
"net_gex": 255.43
},
{
"strike": 37.0,
"call_gex": 41439.82,
"put_gex": -418.26,
"net_gex": 41021.56
},
{
"strike": 38.0,
"call_gex": 482.65,
"put_gex": -4231.77,
"net_gex": -3749.12
},
{
"strike": 39.0,
"call_gex": 71756.18,
"put_gex": -475.57,
"net_gex": 71280.61
},
{
"strike": 40.0,
"call_gex": 27641.29,
"put_gex": -5305.42,
"net_gex": 22335.87
},
{
"strike": 41.0,
"call_gex": 1826.57,
"put_gex": -452.39,
"net_gex": 1374.17
},
{
"strike": 42.0,
"call_gex": 4937.37,
"put_gex": 0.0,
"net_gex": 4937.37
},
{
"strike": 43.0,
"call_gex": 16.91,
"put_gex": -27.54,
"net_gex": -10.62
},
{
"strike": 44.0,
"call_gex": 351.15,
"put_gex": 0.0,
"net_gex": 351.15
},
{
"strike": 45.0,
"call_gex": 55881.94,
"put_gex": 0.0,
"net_gex": 55881.94
},
{
"strike": 46.0,
"call_gex": 33.58,
"put_gex": 0.0,
"net_gex": 33.58
}
]
},
"oi_changes": {
"net_call_oi_change": -5,
"net_put_oi_change": 0,
"top": [
{
"strike": "37",
"oi_change": -5,
"type": "call"
},
{
"strike": "39",
"oi_change": 0,
"type": "call"
},
{
"strike": "32",
"oi_change": 0,
"type": "put"
},
{
"strike": "45",
"oi_change": 0,
"type": "call"
},
{
"strike": "45",
"oi_change": 0,
"type": "call"
}
]
},
"opds": {
"opds": -3.7,
"D": -11.1,
"P": 3.1,
"O": -19.2,
"C": 33.0,
"signal": "NEUTRAL",
"direction": "bearish",
"coverage": 0.7,
"ranked": true,
"components": {
"M": 34.8,
"T": -32.7,
"RS": -4.8,
"V": 0.0,
"F": 69.4,
"OI": -100.0,
"S": -100.0,
"IV": null,
"B": null,
"Liquidity": 10.6,
"OpeningConfidence": null,
"FlowAgreement": 66.7,
"StrikeBreadth": null
},
"drivers": [
"- open-interest change -100",
"- skew -100",
"+ aggressive flow +69",
"+ momentum +35",
"- trend -33"
]
}
}
Data:
{
"vix": 16.87,
"sp500": 7718.94,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.37,
"hy_spread": 3.16,
"treasury": {
"date": "2026-10-16",
"month1": 4.12,
"month2": 4.17,
"month3": 4.26,
"month6": 4.34,
"year1": 4.46,
"year2": 4.74,
"year3": 4.82,
"year5": 4.89,
"year7": 4.98,
"year10": 5.09,
"year20": 5.47,
"year30": 5.43
},
"events": []
}
Data:
{
"days": 103,
"patterns": [
{
"name": "VWAP Touch",
"count": 103,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 102,
"pct": 99
},
{
"name": "Woodie Pivot Touch",
"count": 99,
"pct": 96
},
{
"name": "PDH/PDL Touch",
"count": 88,
"pct": 85
},
{
"name": "Open Retracement",
"count": 73,
"pct": 71
},
{
"name": "Gap Fill",
"count": 73,
"pct": 71
},
{
"name": "High Vol Open",
"count": 20,
"pct": 19
},
{
"name": "Darvas Box",
"count": 14,
"pct": 14
},
{
"name": "Power Hour",
"count": 13,
"pct": 13
}
]
}